Clinical Pharmacology and Therapeutics 2017-Nov
Development of Molecularly Targeted Therapies to Treat Pediatric Malignancies.
只有注册用户可以翻译文章
登陆注册
链接已保存到剪贴板
关键词
抽象
Drugs and biologics developed to treat children with cancer have been historically developed in adults for adult indications. Although leading to many useful drugs and biologics to treat pediatric cancer, future development of molecularly targeted therapies (MTTs) should be directed toward pediatric tumors more specifically to maximize antitumor efficacy while minimizing acute morbidity and long-term disability. This will put pediatric clinicians closer to the goal of cure for all children diagnosed with cancer.